NASDAQ:MGTX MeiraGTx (MGTX) Stock Price, News & Analysis $10.79 +0.13 (+1.22%) Closing price 04:00 PM EasternExtended Trading$10.82 +0.03 (+0.30%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About MeiraGTx Stock (NASDAQ:MGTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MeiraGTx alerts:Sign Up Key Stats Today's Range$10.66▼$11.0050-Day Range$10.66▼$14.9752-Week Range$6.62▼$15.35Volume820,035 shsAverage Volume939,208 shsMarket Capitalization$1.04 billionP/E Ratio15.20Dividend YieldN/APrice Target$24.71Consensus RatingModerate Buy Company Overview MeiraGTx Holdings plc (NASDAQ:MGTX) is a clinical-stage biotechnology company developing gene therapy and ribonucleic acid (RNA) medicines for diseases with significant unmet medical needs. Its research focuses primarily on the central nervous system, immune-mediated conditions and disorders affecting salivary gland function. The company’s technology platforms are designed to deliver therapeutic genes or regulate gene expression in targeted tissues. Its investigational programs have included gene therapies for Parkinson’s disease and radiation-induced xerostomia, a condition involving chronic dry mouth after cancer treatment. MeiraGTx has also pursued additional programs in neurological and other serious diseases, although its pipeline and development priorities may change as clinical studies progress. Founded in 2015, MeiraGTx has built research, development and manufacturing capabilities in the United States and the United Kingdom. The company is led by Alexandra Forbes, who co-founded MeiraGTx and serves as president and chief executive officer.AI Generated. May Contain Errors. Read More MeiraGTx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreMGTX MarketRank™: MeiraGTx scored higher than 73% of companies evaluated by MarketBeat, and ranked 161st out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingMeiraGTx has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 1 strong buy rating, 5 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialMeiraGTx has a consensus price target of $24.71, representing about 129.0% upside from its current price of $10.79.Amount of Analyst CoverageMeiraGTx has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MeiraGTx's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for MeiraGTx are expected to decrease in the coming year, from $0.30 to ($2.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MeiraGTx is 15.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.25.Price to Earnings Ratio vs. SectorThe P/E ratio of MeiraGTx is 15.20, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 214.49.Read more about MeiraGTx's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.51% of the float of MeiraGTx has been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 6.08.Change versus previous monthShort interest in MeiraGTx has recently increased by 7.75%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMeiraGTx does not currently pay a dividend.Dividend GrowthMeiraGTx does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.52 News SentimentMeiraGTx has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for MeiraGTx this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for MGTX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,969,233.00 in company stock.Percentage Held by Insiders7.40% of the stock of MeiraGTx is held by insiders.Percentage Held by Institutions67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MeiraGTx's insider trading history. Receive MGTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MGTX Stock News HeadlinesFinancial Survey: aTyr Pharma (NASDAQ:ATYR) vs. MeiraGTx (NASDAQ:MGTX)October 2 at 5:29 AM | americanbankingnews.comMeiraGTx Holdings PLC (NASDAQ:MGTX) Stock Now Rated "Moderate Buy" by Wall Street BrokeragesOctober 2 at 4:29 AM | americanbankingnews.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.October 2 at 1:00 AM | Profits Run (Ad)Analyzing MeiraGTx (NASDAQ:MGTX) and GeoVax Labs (NASDAQ:GOVX)September 28, 2026 | americanbankingnews.comMeiraGTx (NASDAQ:MGTX) Research Coverage Started at The Goldman Sachs GroupSeptember 27, 2026 | americanbankingnews.comMeiraGTx (NASDAQ:MGTX) Cut to "Hold" at Wall Street ZenSeptember 26, 2026 | americanbankingnews.comGoldman Sachs Initiates MeiraGTx at Neutral With $16 Price TargetSeptember 24, 2026 | marketscreener.comMMeiraGTx Holdings plc Announces Appointment of Alan M. Sebulsky to its Board of DirectorsSeptember 23, 2026 | marketscreener.comMSee More Headlines MGTX Stock Analysis - Frequently Asked Questions How have MGTX shares performed this year? MeiraGTx's stock was trading at $7.95 at the beginning of the year. Since then, MGTX shares have increased by 35.7% and is now trading at $10.79. How were MeiraGTx's earnings last quarter? MeiraGTx Holdings PLC (NASDAQ:MGTX) issued its earnings results on Thursday, August, 13th. The company reported $1.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.46) by $2.17. The firm earned $321.43 million during the quarter, compared to analyst estimates of $0.70 million. MeiraGTx had a net margin of 19.87% and a trailing twelve-month return on equity of 283.85%. When did MeiraGTx IPO? MeiraGTx (MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager. How do I buy shares of MeiraGTx? Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MeiraGTx own? Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA). Company Calendar Last Earnings8/13/2026Today10/02/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (16m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 MGTX's financial health is in the Green zone, according to TradeSmith. MGTX has been in this zone for over 16 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:MGTX CIK1735438 Webwww.meiragtx.com Phone(646) 860-7985FaxN/AEmployees393Year Founded2015Price Target and Rating Average Price Target for MeiraGTx$24.71 High Price Target$35.00 Low Price Target$16.00 Potential Upside/Downside+129.0%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.71 Trailing P/E Ratio15.20 Forward P/E Ratio35.97 P/E GrowthN/ANet Income-$114.20 million Net Margins19.87% Pretax Margin20.45% Return on Equity283.85% Return on Assets29.39% Debt Debt-to-Equity Ratio0.46 Current Ratio3.76 Quick Ratio3.76 Sales & Book Value Annual Sales$81.39 million Price / Sales12.73 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-154.14Miscellaneous Outstanding Shares96,040,000Free Float88,936,000Market Cap$1.04 billion OptionableOptionable Beta1.35 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:MGTX) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
